» Articles » PMID: 37169596

Efficient and Accurate KIR and HLA Genotyping with Massively Parallel Sequencing Data

Overview
Journal Genome Res
Specialty Genetics
Date 2023 May 11
PMID 37169596
Authors
Affiliations
Soon will be listed here.
Abstract

Killer cell immunoglobulin like receptor (KIR) genes and human leukocyte antigen (HLA) genes play important roles in innate and adaptive immunity. They are highly polymorphic and cannot be genotyped with standard variant calling pipelines. Compared with HLA genes, many KIR genes are similar to each other in sequences and may be absent in the chromosomes. Therefore, although many tools have been developed to genotype HLA genes using common sequencing data, none of them work for KIR genes. Even specialized KIR genotypers could not resolve all the KIR genes. Here we describe T1K, a novel computational method for the efficient and accurate inference of KIR or HLA alleles from RNA-seq, whole-genome sequencing, or whole-exome sequencing data. T1K jointly considers alleles across all genotyped genes, so it can reliably identify present genes and distinguish homologous genes, including the challenging / genes. This model also benefits HLA genotyping, where T1K achieves high accuracy in benchmarks. Moreover, T1K can call novel single-nucleotide variants and process single-cell data. Applying T1K to tumor single-cell RNA-seq data, we found that expression was enriched in tumor-specific CD8 T cells. T1K may open the opportunity for HLA and KIR genotyping across various sequencing applications.

Citing Articles

Locityper: targeted genotyping of complex polymorphic genes.

Prodanov T, Plender E, Seebohm G, Meuth S, Eichler E, Marschall T bioRxiv. 2025; .

PMID: 39990346 PMC: 11844405. DOI: 10.1101/2024.05.03.592358.


Comprehensive Profiling of Computational Techniques for Sequencing-Based HLA Immune Signatures Extraction.

Jiang L, Baker S, Ceccarelil M, Guo Y HLA. 2025; 105(2):e70049.

PMID: 39957309 PMC: 11839181. DOI: 10.1111/tan.70049.


Geny: a genotyping tool for allelic decomposition of killer cell immunoglobulin-like receptor genes.

Zhou Q, Ghezelji M, Hari A, Ford M, Holley C, Sahinalp S Front Immunol. 2025; 15():1494995.

PMID: 39763645 PMC: 11701374. DOI: 10.3389/fimmu.2024.1494995.


A walk through the development of human leukocyte antigen typing: from serologic techniques to next-generation sequencing.

Choi H, Choi E, Kim H, Baek I, Won A, Park S Clin Transplant Res. 2024; 38(4):294-308.

PMID: 39658458 PMC: 11732764. DOI: 10.4285/ctr.24.0055.


Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial.

Li R, Villa N, Yu X, Johnson J, Borjas G, Dhillon J Nat Med. 2024; 31(1):176-188.

PMID: 39521884 DOI: 10.1038/s41591-024-03324-9.


References
1.
Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik W, Tosti A . Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002; 295(5562):2097-100. DOI: 10.1126/science.1068440. View

2.
de Vries N, van de Haar J, Veninga V, Chalabi M, Ijsselsteijn M, van der Ploeg M . γδ T cells are effectors of immunotherapy in cancers with HLA class I defects. Nature. 2023; 613(7945):743-750. PMC: 9876799. DOI: 10.1038/s41586-022-05593-1. View

3.
Dobin A, Davis C, Schlesinger F, Drenkow J, Zaleski C, Jha S . STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012; 29(1):15-21. PMC: 3530905. DOI: 10.1093/bioinformatics/bts635. View

4.
Claeys A, Merseburger P, Staut J, Marchal K, Van den Eynden J . Benchmark of tools for in silico prediction of MHC class I and class II genotypes from NGS data. BMC Genomics. 2023; 24(1):247. PMC: 10170851. DOI: 10.1186/s12864-023-09351-z. View

5.
Thuesen N, Schantz Klausen M, Gopalakrishnan S, Trolle T, Renaud G . Benchmarking freely available HLA typing algorithms across varying genes, coverages and typing resolutions. Front Immunol. 2022; 13:987655. PMC: 9679531. DOI: 10.3389/fimmu.2022.987655. View